�Taking 1000mg of a specific olive leaf extract (EFLA�943) can buoy lower cholesterol and lour blood atmospheric pressure in patients with meek hypertension (high blood pressure). These findings came from a 'Twins' trial, in which different treatments were given to identical twins. By doing this, researchers could addition the power of their data by eliminating some of the uncertainties caused by genic variations 'tween individual people.
The enquiry is published in the latest edition of Phytotherapy Research.
Hypertension is one of the most common and significant disease risk factors imposed by the modern life-style. Many people would thence benefit from finding slipway of reducing blood pressing. Experiments in rats had previously indicated that olive leaf extract could be one path of achieving this end.
To test this in humans, researchers from Switzerland and Germany conducted a pilot trial with 20 identical (monozygotic) twin pairs who had an increased blood pressure. Individuals were either granted placebo capsules or capsules containing doses of 500mg or 1000mg of olive leaf extract EFLA�943. Pairs of twins were assigned to different treatments. After the subjects had taken the draw out for octad weeks researchers measured blood pressures as well as collecting data about aspects of life style.
"The study confirmed that olive folio extract EFLA�943 has antihypertensive drug properties in humans," says one of the co-authors, Cem Aydogan, General Manager, Frutarom Health.
"This whole kit and boodle showed that taking a 1000mg dosage has substantial effects in people with borderline hypertension," says Aydogan.
Full citation: Perrinjaquet-Moccetti T, Busjahn A, Schmidlin C, Schmidt A, Bradl B, Aydogan C. Food Supplementation with and Olive (Olea europea L.) leaf extract reduces blood pressure in borderline hypertensive monozygotic gemini the Twins. Phtotherapy research 2008; 22. DOI: 10.1002/ptr.2455
Phytotherapy Research is an external journal for the publishing of original medicinal imbed research, direction on pharmacological medicine, toxicology and the clinical applications of herbs and natural products in practice of medicine. Papers concerned with the effects of common solid food ingredients and standardised plant extracts, including commercial products, and mechanistic studies on isolated instinctive products are particularly welcome. Papers and communications range from case studies to full clinical trials, including studies of herb-drug interactions and other aspects of the safety of herb tea medicines. Phytotherapy Research throne be accessed online at: http://www.interscience.wiley.com/journal/ptr
Wiley-Blackwell was formed in February 2007 as a result of the acquisition of Blackwell Publishing Ltd. by John Wiley & Sons, Inc., and its merger with Wiley's Scientific, Technical, and Medical line. Together, the companies get created a global publishing business with deep military capability in every major academic and professional field. Wiley-Blackwell publishes approximately 1,four hundred scholarly peer-reviewed journals and an extended collection of books with global attract. For more information on Wiley-Blackwell, please visit hypertext transfer protocol://www.blackwellpublishing.com or http://interscience.wiley.com.
More info
Friday 5 September 2008
Subscribe to:
Posts (Atom)